精华制药：孙公司宁夏森萱因污染环境罪被判处罚金五十万元

Core Viewpoint - Jinghua Pharmaceutical (002349.SZ) announced that its subsidiary, Ningxia Senxuan Pharmaceutical Co., Ltd., was fined 500,000 RMB for environmental pollution, which will be offset by a previously paid fine of 900,000 RMB, resulting in no further payment required. The case amount is relatively small and will not significantly impact the company's net profit for 2025. Following the incident, Ningxia Senxuan has taken corrective actions and is expected to resume normal operations by July 2024. The judicial outcome of this case will not lead to any major legal violations that could trigger forced delisting of the company [1]. Summary by Category - Legal and Financial Impact - The fine imposed on Ningxia Senxuan is 500,000 RMB, which is offset by a previously paid fine of 900,000 RMB, meaning no additional payment is necessary [1] - The case amount is considered small and is not expected to have a significant effect on the company's net profit for 2025 [1] - Operational Response - Ningxia Senxuan has taken the incident seriously and has implemented corrective measures [1] - The company is projected to resume normal production and operations by July 2024 [1] - Regulatory Implications - The outcome of the case will not result in any major legal violations that could lead to forced delisting of the company [1]